Shares of Indegene Limited climbed 2% after the company announced the opening of a new center in London as part of its strategic expansion in Europe. The move is aimed at strengthening its ability to support life sciences clients in the region by offering advanced consulting and commercialization solutions with an AI-first approach.
The newly established London center will serve as a key hub for Indegene’s European clients, helping them modernize operations and enhance customer engagement through innovative digital solutions. The company also plans to expand its workforce in the region, with a focus on consulting, data analytics, engineering, and customer experience, reinforcing its expertise in life sciences commercialization.
Manish Gupta, Chairman and CEO of Indegene, highlighted London’s significance as a global center for healthcare, technology, and business innovation. He emphasized that the new center would allow the company to drive innovation and help clients improve their commercialization processes, leveraging the city’s strong talent pool and dynamic business environment.
This expansion follows Indegene’s recent establishment of a new entity in Spain, adding to its growing European footprint, which includes operational centers in Germany, Ireland, and Switzerland. The company has also made strategic acquisitions in the region, such as Trilogy Writing & Consulting GmbH and DT Consulting, further enhancing its capabilities in medical writing and healthcare consulting. The move underscores Indegene’s commitment to scaling its global presence while catering to the evolving needs of the life sciences industry.
